Literature DB >> 17873541

Glucagonoma syndrome: survival 21 years with concurrent liver metastases.

Spyros P Dourakis1, Alexandra Alexopoulou, Kleoniki K Georgousi, Johanna K Delladetsima, George Tolis, Athanasios J Archimandritis.   

Abstract

A patient who survived for 21 years since initial discovery of glucagonoma with concurrent liver metastases is described. Psychiatric symptoms, weight loss, necrolytic migratory erythema, diarrhea, and diabetes mellitus developed gradually after diagnosis of the tumor. No specific treatment was administered. The longevity of this patient may be related to the slow tumor growth expressed histologically by ischemic necrosis of the malignant cells and in imaging by extensive tumor calcifications, a very rare finding in this type of the tumor.

Entities:  

Mesh:

Year:  2007        PMID: 17873541     DOI: 10.1097/MAJ.0b013e318141ff0b

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  1 in total

1.  Metastatic glucagonoma.

Authors:  Bulent Dinc; Cankat Sahin
Journal:  Eurasian J Med       Date:  2009-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.